COPD Trial, Recruiting NCT04200079 Sponsor: Dr. Juan Pablo de Torres Tajes Condition: COPD
Back to Copd

COPD Trial, Recruiting

NCT04200079
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between the ages of 40 and 85 years old
  • People who have smoked at least 10 pack-years (roughly the equivalent of one pack per day for 10 years) in their lifetime
  • People who currently smoke or who used to smoke
  • People who have been diagnosed with COPD based on a specific breathing test result (a lung function test showing an FEV1/FVC ratio of 0.70 or below after using a bronchodilator), including those who also have conditions such as asthma, bronchiectasis, stable lung cancer, or a lung scarring condition
  • People who are able to complete all required study tests, including lung function tests, a six-minute walk test, and a chest CT scan, and who are willing to sign a consent form

Who may not be able to join:

  • People who are not willing to sign the consent form
  • People whose life expectancy is estimated to be less than 3 years
  • People who are currently receiving palliative care
  • People who have a similar breathing obstruction result on their lung test but whose condition is caused by something other than smoking, or who do not have at least a 10 pack-year smoking history
  • People who are unable to complete the required lung function tests, six-minute walk test, or chest CT scan

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Juan P de Torres, MD, Queen's University

Phone: 613 549 6666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Dr. Juan Pablo de Torres Tajes
Registry
ClinicalTrials.gov
Start date
14 January 2020
Est. completion
31 December 2030

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Mortality; Exacerbations

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov